Table 3 Utility and utility decrements associated with health states and treatments included in the model (measured by EQ-5D) from reference 30
Health State | Utility (SE) |
|---|---|
Non-valvular atrial fibrillation | 0.7270 (0.0095) |
Stroke (ischemic or hemorrhagic) | 0.6151 (0.0299) |
Mild | 0.5646 (0.0299) |
0.5142 (0.0299) | |
Moderate | |
Severe | 0.6151 (0.0299) |
Myocardial infarction | 0.5646 (0.0299) |
0.6265 (0.0299) | |
Females | |
Males | |
Systemic embolism | |
Transient health states/anticoagulation use | Utility decrements (SE/95 % CI) |
Other intracranial haemorrhage | 0.1511 (0.0401) |
Other major | 0.1511 (0.0401) |
Clinically relevant non-major bleed | 0.0582 (0.0173) |
Other cardiovascular hospitalization | 0.1276 (0.0259) |
Use of Apixaban or aspirin | 0.0020 (0.00-0.04) |
Use of Warfarin | 0.0120 (0.00-0.08) |